BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21168468)

  • 1. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
    Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
    Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
    Ramirez P; Rettig MP; Uy GL; Deych E; Holt MS; Ritchey JK; DiPersio JF
    Blood; 2009 Aug; 114(7):1340-3. PubMed ID: 19571319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
    Uy GL; Rettig MP; Cashen AF
    Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells.
    Christopherson KW; Cooper S; Broxmeyer HE
    Blood; 2003 Jun; 101(12):4680-6. PubMed ID: 12576320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
    Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
    Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule Me6TREN mobilizes hematopoietic stem/progenitor cells by activating MMP-9 expression and disrupting SDF-1/CXCR4 axis.
    Zhang J; Ren X; Shi W; Wang S; Chen H; Zhang B; Wang Z; Zhou Y; Chen L; Zhang R; Lv Y; Zhou J; Nan X; He L; Yue W; Li Y; Pei X
    Blood; 2014 Jan; 123(3):428-41. PubMed ID: 24196072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
    Theiss HD; Vallaster M; Rischpler C; Krieg L; Zaruba MM; Brunner S; Vanchev Y; Fischer R; Gröbner M; Huber B; Wollenweber T; Assmann G; Mueller-Hoecker J; Hacker M; Franz WM
    Stem Cell Res; 2011 Nov; 7(3):244-55. PubMed ID: 21752744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
    Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
    Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice.
    Christopherson KW; Cooper S; Hangoc G; Broxmeyer HE
    Exp Hematol; 2003 Nov; 31(11):1126-34. PubMed ID: 14585379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenaline administration promotes the efficiency of granulocyte colony stimulating factor-mediated hematopoietic stem and progenitor cell mobilization in mice.
    Chen C; Cao J; Song X; Zeng L; Li Z; Li Y; Xu K
    Int J Hematol; 2013 Jan; 97(1):50-7. PubMed ID: 23224606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In and out of the niche: perspectives in mobilization of hematopoietic stem cells.
    Mohty M; Ho AD
    Exp Hematol; 2011 Jul; 39(7):723-9. PubMed ID: 21624427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
    Pusic I; DiPersio JF
    Curr Opin Hematol; 2010 Jul; 17(4):319-26. PubMed ID: 20473162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100.
    Bonig H; Chudziak D; Priestley G; Papayannopoulou T
    Exp Hematol; 2009 Mar; 37(3):402-15.e1. PubMed ID: 19157683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 and mobilization of hematopoietic precursors.
    Rettig MP; Ramirez P; Nervi B; DiPersio JF
    Methods Enzymol; 2009; 460():57-90. PubMed ID: 19446720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.
    Dar A; Schajnovitz A; Lapid K; Kalinkovich A; Itkin T; Ludin A; Kao WM; Battista M; Tesio M; Kollet O; Cohen NN; Margalit R; Buss EC; Baleux F; Oishi S; Fujii N; Larochelle A; Dunbar CE; Broxmeyer HE; Frenette PS; Lapidot T
    Leukemia; 2011 Aug; 25(8):1286-1296. PubMed ID: 21494253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1α in an Alzheimer's disease mouse model.
    Shin JW; Lee JK; Lee JE; Min WK; Schuchman EH; Jin HK; Bae JS
    Stem Cells; 2011 Jul; 29(7):1075-89. PubMed ID: 21608078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
    Flomenberg N; DiPersio J; Calandra G
    Acta Haematol; 2005; 114(4):198-205. PubMed ID: 16269859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
    De Clercq E
    Pharmacol Ther; 2010 Dec; 128(3):509-18. PubMed ID: 20826182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.